22
May
Emcure Pharmaceuticals Limited (EPL) has announced the launch of Orofer FCM 750, a new extension of its parenteral iron brand containing Ferric carboxymaltose (FCM).Orofer FCM is a new dosage variant designed to provide a more effective and convenient option for patients with iron deficiency and AIDS. It is available in 1000mg/ 20ml and 500mg/ 10ml single-use vials, and can be obtained through a prescription from a registered medical practitioner. Indian studies have indicated that most patients need FCM 1500 mg at body weight between 35-70 kgs. A single dose of FCM up to 750 mg of iron can be infused…
